Influenza vaccine efficacy induced by orally administered recombinant baculoviruses
Although vaccine delivery through the oral route remains the most convenient and safest way for mass immunization purposes, this method is limited by the requirement for large antigen doses and low vaccine efficacy. In this study, we generated recombinant baculoviruses (rBVs) expressing influenza he...
Gespeichert in:
Veröffentlicht in: | PloS one 2020-05, Vol.15 (5), p.e0233520-e0233520 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e0233520 |
---|---|
container_issue | 5 |
container_start_page | e0233520 |
container_title | PloS one |
container_volume | 15 |
creator | Basak, Swarnendu Kang, Hae-Ji Lee, Su-Hwa Chu, Ki-Back Moon, Eun-Kyung Quan, Fu-Shi |
description | Although vaccine delivery through the oral route remains the most convenient and safest way for mass immunization purposes, this method is limited by the requirement for large antigen doses and low vaccine efficacy. In this study, we generated recombinant baculoviruses (rBVs) expressing influenza hemagglutinin (A/PR/8/34) and orally delivered a low dose of rBVs to evaluate its vaccine efficacy in mice. Intranasal rBV vaccination was included in the whole experiment for comparison. We found that oral vaccination elicited high levels of virus-specific IgG and IgA antibody responses in both serum and mucosal samples (lung, tracheal, intestinal, fecal and vaginal). Surprisingly, complete protection from the lethal influenza challenge was observed, as indicated by reductions in the virus titer, inflammatory cytokine production, body weight change, and enhanced survival. These results suggest that oral delivery of the influenza rBV vaccine induces mucosal and systemic immunity, which protect mice from the lethal influenza virus challenge. Oral delivery of baculovirus vaccines can be developed as an effective vaccination route. |
doi_str_mv | 10.1371/journal.pone.0233520 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2407307257</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A625022576</galeid><doaj_id>oai_doaj_org_article_c990545c91444132a659d6640f2d6cd5</doaj_id><sourcerecordid>A625022576</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-b28af733e6ac8732bae7cca9cec8121622ad744d878edb213499a02c5acea0c83</originalsourceid><addsrcrecordid>eNqNkt-L1DAQx4so3rn6H4gWBNGHXdOkTdsX4Tj8sXBw4KmvYTpJd7OkyV7SLq5_vVm3d2zlHiQPCZPPfJOZ-SbJy4wsMlZmHzZu8BbMYuusWhDKWEHJo-Q8qxmdc0rY45PzWfIshA0hBas4f5qcMZoXdUXZeXKztK0ZlP0N6Q4QtVWpaluNgPtUWzmgkmmzT50HY_YpyE5bHXrlY9grdF2jLdg-bQAH43baD0GF58mTFkxQL8Z9lvz4_On75df51fWX5eXF1Rx5Tft5QytoS8YUB6xKRhtQJSLUqLDKaMYpBVnmuazKSsmGZiyvayAUC0AFBCs2S14fdbfGBTH2Iwiak5KRkhZlJJZHQjrYiK3XHfi9cKDF34DzKwG-12iUwLomRV5gneV5njEKvKgl5zlpqeQoi6j1cXxtaDolUdk-NmUiOr2xei1WbifiTyiP85kl70YB724HFXrR6YDKGLDKDcd_F2Vd1nlE3_yDPlzdSK0gFqBt6-K7eBAVF5wWhEaIR2rxABWXVJ3GaJ5Wx_gk4f0kITK9-tWvYAhBLG--_T97_XPKvj1h1wpMvw7ODL12NkzB_AiidyF41d43OSPi4P27boiD98Xo_Zj26nRA90l3Zmd_AKvo_uQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2407307257</pqid></control><display><type>article</type><title>Influenza vaccine efficacy induced by orally administered recombinant baculoviruses</title><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>PubMed (Medline)</source><source>Free Full-Text Journals in Chemistry</source><source>EZB Electronic Journals Library</source><creator>Basak, Swarnendu ; Kang, Hae-Ji ; Lee, Su-Hwa ; Chu, Ki-Back ; Moon, Eun-Kyung ; Quan, Fu-Shi</creator><contributor>Huber, Victor C</contributor><creatorcontrib>Basak, Swarnendu ; Kang, Hae-Ji ; Lee, Su-Hwa ; Chu, Ki-Back ; Moon, Eun-Kyung ; Quan, Fu-Shi ; Huber, Victor C</creatorcontrib><description>Although vaccine delivery through the oral route remains the most convenient and safest way for mass immunization purposes, this method is limited by the requirement for large antigen doses and low vaccine efficacy. In this study, we generated recombinant baculoviruses (rBVs) expressing influenza hemagglutinin (A/PR/8/34) and orally delivered a low dose of rBVs to evaluate its vaccine efficacy in mice. Intranasal rBV vaccination was included in the whole experiment for comparison. We found that oral vaccination elicited high levels of virus-specific IgG and IgA antibody responses in both serum and mucosal samples (lung, tracheal, intestinal, fecal and vaginal). Surprisingly, complete protection from the lethal influenza challenge was observed, as indicated by reductions in the virus titer, inflammatory cytokine production, body weight change, and enhanced survival. These results suggest that oral delivery of the influenza rBV vaccine induces mucosal and systemic immunity, which protect mice from the lethal influenza virus challenge. Oral delivery of baculovirus vaccines can be developed as an effective vaccination route.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0233520</identifier><identifier>PMID: 32459823</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Antibodies ; Antigens ; B cells ; Baculovirus ; Baculoviruses ; Biology and Life Sciences ; Body weight ; Cytokines ; DNA vaccines ; Dosage and administration ; Drug delivery systems ; Health aspects ; Hemagglutinins ; Immunization ; Immunoglobulin A ; Immunoglobulin G ; Inflammation ; Influenza ; Influenza vaccines ; Influenza viruses ; Intestine ; Lectins ; Medical research ; Medicine and Health Sciences ; Mucosa ; Mucosal immunity ; Oral administration ; Respiratory system ; Vaccination ; Vaccine efficacy ; Vaccines ; Vagina ; Viruses ; Zoology</subject><ispartof>PloS one, 2020-05, Vol.15 (5), p.e0233520-e0233520</ispartof><rights>COPYRIGHT 2020 Public Library of Science</rights><rights>2020 Basak et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 Basak et al 2020 Basak et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-b28af733e6ac8732bae7cca9cec8121622ad744d878edb213499a02c5acea0c83</citedby><cites>FETCH-LOGICAL-c692t-b28af733e6ac8732bae7cca9cec8121622ad744d878edb213499a02c5acea0c83</cites><orcidid>0000-0003-0419-9339</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252623/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252623/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,2928,23866,27924,27925,53791,53793,79600,79601</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32459823$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Huber, Victor C</contributor><creatorcontrib>Basak, Swarnendu</creatorcontrib><creatorcontrib>Kang, Hae-Ji</creatorcontrib><creatorcontrib>Lee, Su-Hwa</creatorcontrib><creatorcontrib>Chu, Ki-Back</creatorcontrib><creatorcontrib>Moon, Eun-Kyung</creatorcontrib><creatorcontrib>Quan, Fu-Shi</creatorcontrib><title>Influenza vaccine efficacy induced by orally administered recombinant baculoviruses</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Although vaccine delivery through the oral route remains the most convenient and safest way for mass immunization purposes, this method is limited by the requirement for large antigen doses and low vaccine efficacy. In this study, we generated recombinant baculoviruses (rBVs) expressing influenza hemagglutinin (A/PR/8/34) and orally delivered a low dose of rBVs to evaluate its vaccine efficacy in mice. Intranasal rBV vaccination was included in the whole experiment for comparison. We found that oral vaccination elicited high levels of virus-specific IgG and IgA antibody responses in both serum and mucosal samples (lung, tracheal, intestinal, fecal and vaginal). Surprisingly, complete protection from the lethal influenza challenge was observed, as indicated by reductions in the virus titer, inflammatory cytokine production, body weight change, and enhanced survival. These results suggest that oral delivery of the influenza rBV vaccine induces mucosal and systemic immunity, which protect mice from the lethal influenza virus challenge. Oral delivery of baculovirus vaccines can be developed as an effective vaccination route.</description><subject>Antibodies</subject><subject>Antigens</subject><subject>B cells</subject><subject>Baculovirus</subject><subject>Baculoviruses</subject><subject>Biology and Life Sciences</subject><subject>Body weight</subject><subject>Cytokines</subject><subject>DNA vaccines</subject><subject>Dosage and administration</subject><subject>Drug delivery systems</subject><subject>Health aspects</subject><subject>Hemagglutinins</subject><subject>Immunization</subject><subject>Immunoglobulin A</subject><subject>Immunoglobulin G</subject><subject>Inflammation</subject><subject>Influenza</subject><subject>Influenza vaccines</subject><subject>Influenza viruses</subject><subject>Intestine</subject><subject>Lectins</subject><subject>Medical research</subject><subject>Medicine and Health Sciences</subject><subject>Mucosa</subject><subject>Mucosal immunity</subject><subject>Oral administration</subject><subject>Respiratory system</subject><subject>Vaccination</subject><subject>Vaccine efficacy</subject><subject>Vaccines</subject><subject>Vagina</subject><subject>Viruses</subject><subject>Zoology</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNkt-L1DAQx4so3rn6H4gWBNGHXdOkTdsX4Tj8sXBw4KmvYTpJd7OkyV7SLq5_vVm3d2zlHiQPCZPPfJOZ-SbJy4wsMlZmHzZu8BbMYuusWhDKWEHJo-Q8qxmdc0rY45PzWfIshA0hBas4f5qcMZoXdUXZeXKztK0ZlP0N6Q4QtVWpaluNgPtUWzmgkmmzT50HY_YpyE5bHXrlY9grdF2jLdg-bQAH43baD0GF58mTFkxQL8Z9lvz4_On75df51fWX5eXF1Rx5Tft5QytoS8YUB6xKRhtQJSLUqLDKaMYpBVnmuazKSsmGZiyvayAUC0AFBCs2S14fdbfGBTH2Iwiak5KRkhZlJJZHQjrYiK3XHfi9cKDF34DzKwG-12iUwLomRV5gneV5njEKvKgl5zlpqeQoi6j1cXxtaDolUdk-NmUiOr2xei1WbifiTyiP85kl70YB724HFXrR6YDKGLDKDcd_F2Vd1nlE3_yDPlzdSK0gFqBt6-K7eBAVF5wWhEaIR2rxABWXVJ3GaJ5Wx_gk4f0kITK9-tWvYAhBLG--_T97_XPKvj1h1wpMvw7ODL12NkzB_AiidyF41d43OSPi4P27boiD98Xo_Zj26nRA90l3Zmd_AKvo_uQ</recordid><startdate>20200527</startdate><enddate>20200527</enddate><creator>Basak, Swarnendu</creator><creator>Kang, Hae-Ji</creator><creator>Lee, Su-Hwa</creator><creator>Chu, Ki-Back</creator><creator>Moon, Eun-Kyung</creator><creator>Quan, Fu-Shi</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-0419-9339</orcidid></search><sort><creationdate>20200527</creationdate><title>Influenza vaccine efficacy induced by orally administered recombinant baculoviruses</title><author>Basak, Swarnendu ; Kang, Hae-Ji ; Lee, Su-Hwa ; Chu, Ki-Back ; Moon, Eun-Kyung ; Quan, Fu-Shi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-b28af733e6ac8732bae7cca9cec8121622ad744d878edb213499a02c5acea0c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antibodies</topic><topic>Antigens</topic><topic>B cells</topic><topic>Baculovirus</topic><topic>Baculoviruses</topic><topic>Biology and Life Sciences</topic><topic>Body weight</topic><topic>Cytokines</topic><topic>DNA vaccines</topic><topic>Dosage and administration</topic><topic>Drug delivery systems</topic><topic>Health aspects</topic><topic>Hemagglutinins</topic><topic>Immunization</topic><topic>Immunoglobulin A</topic><topic>Immunoglobulin G</topic><topic>Inflammation</topic><topic>Influenza</topic><topic>Influenza vaccines</topic><topic>Influenza viruses</topic><topic>Intestine</topic><topic>Lectins</topic><topic>Medical research</topic><topic>Medicine and Health Sciences</topic><topic>Mucosa</topic><topic>Mucosal immunity</topic><topic>Oral administration</topic><topic>Respiratory system</topic><topic>Vaccination</topic><topic>Vaccine efficacy</topic><topic>Vaccines</topic><topic>Vagina</topic><topic>Viruses</topic><topic>Zoology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Basak, Swarnendu</creatorcontrib><creatorcontrib>Kang, Hae-Ji</creatorcontrib><creatorcontrib>Lee, Su-Hwa</creatorcontrib><creatorcontrib>Chu, Ki-Back</creatorcontrib><creatorcontrib>Moon, Eun-Kyung</creatorcontrib><creatorcontrib>Quan, Fu-Shi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>https://resources.nclive.org/materials</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agriculture Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest Biological Science Journals</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest advanced technologies & aerospace journals</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials science collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Basak, Swarnendu</au><au>Kang, Hae-Ji</au><au>Lee, Su-Hwa</au><au>Chu, Ki-Back</au><au>Moon, Eun-Kyung</au><au>Quan, Fu-Shi</au><au>Huber, Victor C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influenza vaccine efficacy induced by orally administered recombinant baculoviruses</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2020-05-27</date><risdate>2020</risdate><volume>15</volume><issue>5</issue><spage>e0233520</spage><epage>e0233520</epage><pages>e0233520-e0233520</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Although vaccine delivery through the oral route remains the most convenient and safest way for mass immunization purposes, this method is limited by the requirement for large antigen doses and low vaccine efficacy. In this study, we generated recombinant baculoviruses (rBVs) expressing influenza hemagglutinin (A/PR/8/34) and orally delivered a low dose of rBVs to evaluate its vaccine efficacy in mice. Intranasal rBV vaccination was included in the whole experiment for comparison. We found that oral vaccination elicited high levels of virus-specific IgG and IgA antibody responses in both serum and mucosal samples (lung, tracheal, intestinal, fecal and vaginal). Surprisingly, complete protection from the lethal influenza challenge was observed, as indicated by reductions in the virus titer, inflammatory cytokine production, body weight change, and enhanced survival. These results suggest that oral delivery of the influenza rBV vaccine induces mucosal and systemic immunity, which protect mice from the lethal influenza virus challenge. Oral delivery of baculovirus vaccines can be developed as an effective vaccination route.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>32459823</pmid><doi>10.1371/journal.pone.0233520</doi><tpages>e0233520</tpages><orcidid>https://orcid.org/0000-0003-0419-9339</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2020-05, Vol.15 (5), p.e0233520-e0233520 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_2407307257 |
source | DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; PubMed (Medline); Free Full-Text Journals in Chemistry; EZB Electronic Journals Library |
subjects | Antibodies Antigens B cells Baculovirus Baculoviruses Biology and Life Sciences Body weight Cytokines DNA vaccines Dosage and administration Drug delivery systems Health aspects Hemagglutinins Immunization Immunoglobulin A Immunoglobulin G Inflammation Influenza Influenza vaccines Influenza viruses Intestine Lectins Medical research Medicine and Health Sciences Mucosa Mucosal immunity Oral administration Respiratory system Vaccination Vaccine efficacy Vaccines Vagina Viruses Zoology |
title | Influenza vaccine efficacy induced by orally administered recombinant baculoviruses |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T11%3A16%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influenza%20vaccine%20efficacy%20induced%20by%20orally%20administered%20recombinant%20baculoviruses&rft.jtitle=PloS%20one&rft.au=Basak,%20Swarnendu&rft.date=2020-05-27&rft.volume=15&rft.issue=5&rft.spage=e0233520&rft.epage=e0233520&rft.pages=e0233520-e0233520&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0233520&rft_dat=%3Cgale_plos_%3EA625022576%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2407307257&rft_id=info:pmid/32459823&rft_galeid=A625022576&rft_doaj_id=oai_doaj_org_article_c990545c91444132a659d6640f2d6cd5&rfr_iscdi=true |